Aspen Aerogels, Inc. (NYSE:ASPN) Short Interest Update

by · The Cerbat Gem

Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) was the recipient of a significant increase in short interest in September. As of September 30th, there was short interest totalling 6,480,000 shares, an increase of 8.2% from the September 15th total of 5,990,000 shares. Based on an average daily volume of 1,800,000 shares, the days-to-cover ratio is presently 3.6 days.

Insider Activity at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Aspen Aerogels

A number of hedge funds have recently modified their holdings of ASPN. Banque Cantonale Vaudoise increased its position in Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after purchasing an additional 1,252 shares during the last quarter. Harbour Capital Advisors LLC acquired a new stake in Aspen Aerogels during the first quarter worth approximately $404,000. Bridgewater Advisors Inc. acquired a new stake in Aspen Aerogels during the first quarter worth approximately $750,000. BNP Paribas Financial Markets increased its holdings in shares of Aspen Aerogels by 85.2% in the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock valued at $452,000 after acquiring an additional 11,823 shares during the period. Finally, GSA Capital Partners LLP acquired a new position in shares of Aspen Aerogels in the 1st quarter valued at $1,181,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Benchmark restated a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a research note on Thursday, August 8th. TD Cowen raised their price target on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research note on Tuesday, August 20th. Roth Mkm restated a “buy” rating and set a $36.00 price target on shares of Aspen Aerogels in a research note on Wednesday, August 21st. Barclays assumed coverage on Aspen Aerogels in a research note on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price target on the stock. Finally, HC Wainwright restated a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $29.70.

View Our Latest Analysis on ASPN

Aspen Aerogels Stock Down 7.6 %

Shares of ASPN stock traded down $1.94 during trading hours on Thursday, reaching $23.47. 2,332,137 shares of the company’s stock were exchanged, compared to its average volume of 1,416,712. Aspen Aerogels has a 1 year low of $6.62 and a 1 year high of $33.15. The stock has a market cap of $1.79 billion, a PE ratio of -53.70 and a beta of 2.16. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The stock’s fifty day moving average price is $25.98 and its two-hundred day moving average price is $24.33.

Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. The business had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. During the same quarter in the previous year, the firm earned ($0.22) earnings per share. The company’s revenue was up 144.4% on a year-over-year basis. Research analysts predict that Aspen Aerogels will post 0.21 EPS for the current year.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Stories